LARONDE

Serial Number 90089002
606

Registration Progress

Application Filed
Aug 3, 2020
Under Examination
Aug 17, 2021
Approved for Publication
Jun 22, 2021
Published for Opposition
Jun 22, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: LARONDE
Previous Owner: SAIL BIOMEDICINES, INC.
Classes: 005, 042

Trademark Image

LARONDE

Basic Information

Serial Number
90089002
Filing Date
August 3, 2020
Published for Opposition
June 22, 2021
Abandonment Date
September 23, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 23, 2024
Classes
005 042

Rights Holder

SAIL BIOMEDICINES, INC.

03
Address
325 VASSAR ST, STE 1B
CAMBRIDGE, MA 02139

Ownership History

VL50, Inc.

Original Applicant
03
Cambridge, MA

LARONDE, INC

New Owner Before Publication #1
03
CAMBRIDGE, MA

LARONDE, INC

Owner at Publication
03
Cambridge, MA

SAIL BIOMEDICINES, INC.

New Owner After Publication #1
03
CAMBRIDGE, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Sep 23, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 23, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 16, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 16, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 15, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 26, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 6, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 17, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 17, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 17, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 15, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 17, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 22, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 22, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 2, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 19, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 19, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 19, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 19, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 23, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 23, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 23, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 23, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 7, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 3, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders
Class 042
Testing, inspection, research, and development of pharmaceutical preparations for gene therapy

Additional Information

Translation
The English translation of the French wording "LA RONDE" is "THE ROUND"

Classification

International Classes
005 042